fda compounding semaglutide warning 2025 october National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA Issues Warning: Compounding Certain
Description
In select locations, dedicated product displays highlight items that can help manage common issues such as nausea and gastrointestinal discomfort, as well as products that support hydration, protein intake, and overall nutrition
For patients using these medications for weight management, reduced potency may result in diminished weight loss
[DOI] [PubMed] [Google Scholar] 18.Reasner C, Olansky L, Seck TL, et al
Healthy habits that promote long-term weight stability beyond semaglutide treatment
